ALH — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-12

• Gross profit for the three months ended March 31, 2026 increased $12.2 million, or 8.4%, to $157.2 million from $145.0 million for the three months ended March 31, 2025. Gross profit, as a percentage of net revenues, remained relatively flat at 36.8% for the three months ended March 31, 2026 as comp…

• tariffs of approximately $3.4 million negatively impacted gross margin for three months ended March 31, 2026. Tariffs were partially offset by price increases and cost reduction initiatives.

• Selling, general, and administrative expenses for the three months ended March 31, 2026 increased $2.8 million to $73.4 million from $70.5 million for the three months ended March 31, 2025. Selling, general, and administrative expenses as a percentage of net revenues was 17.2% for the three months e…

• Interest expense, net for the three months ended March 31, 2026 decreased $27.0 million to $17.9 million from $44.9 million for the three months ended March 31, 2025. The decrease in interest expense was primarily attributable to a lower debt balance resulting from Term Loan voluntary prepayments, a…

• Other (income)/expenses, net for the three months ended March 31, 2026 was $6.5 million of income compared to $7.1 million of expenses for the three months ended March 31, 2025. Other income for the three months ended March 31, 2026 included $6.5 million of foreign exchange gains on intercompany loa…

Text removed vs the prior filing · source: 10-Q · 2025-11-13

• Gross profit for the three months ended September 30, 2025 increased $19.0 million, or 13.3%, to $162.0 million from $143.0 million for the three months ended September 30, 2024. Gross profit as a percentage of net revenues was 37.0% for the three months ended September 30, 2025 as compared to 37.2%…

• Selling, general, and administrative expenses for the three months ended September 30, 2025 increased $5.4 million to $76.5 million from $71.0 million for the three months ended September 30, 2024. Selling, general, and administrative expenses as a percentage of net revenues was 17.5% for the three …

• Interest expense, net for the three months ended September 30, 2025 decreased $5.4 million to $37.0 million from $42.3 million for the three months ended September 30, 2024. The decrease in interest expense was primarily attributable to a lower interest rate on the Term Loan following refinancing ac…

• Other expenses, net for the three months ended September 30, 2025 was $5.6 million compared to income of $37.3 million for the three months ended September 30, 2024. Other expenses, net for the three months ended September 30, 2025 included $3.2 million foreign exchange losses on intercompany loans,…

• The effective income tax rate was a 23.4% provision for the three months ended September 30, 2025 as compared to a 18.3% benefit for the three months ended September 30, 2024. The increase is primarily due to the limitation of the deductibility of officer compensation under IRC Section 162(m) in 202…

Text added vs the prior filing · source: 10-Q · 2026-05-12

• The Company is exposed to certain risks relating to its ongoing business operations. As a result, the Company enters into derivative transactions to manage these exposures. The primary risks managed through the use of derivative instruments are fluctuations in interest rates, foreign currency exchan…

• Borrowings outstanding under the Term Loan totaled $1,300 million at March 31, 2026. Borrowings under the Term Loan bear interest, at the option of the applicable Borrower, at a rate equal to an applicable margin plus (a) the applicable base rate or (b) Term SOFR (both rates as determined in accorda…

Text removed vs the prior filing · source: 10-Q · 2025-11-13

• The Company is exposed to certain risks relating to its ongoing business operations. As a result, the Company enters into derivative transactions to manage these exposures. The primary risks

• managed through the use of derivative instruments are fluctuations in interest rates, foreign currency exchange rates and commodity prices. Fluctuations in these rates and prices can affect the Company’s operating results and financial condition. The Company manages the exposure to these market risk…

• Borrowings outstanding under the Term Loan totaled $1,940 million at September 30, 2025. Borrowings under the Term Loan bear interest, at the option of the applicable Borrower, at a rate equal to an applicable margin plus (a) the applicable base rate or (b) Term SOFR (both rates as determined in acc…

Text added vs the prior filing · source: 10-Q · 2026-05-12

• As of the end of the period covered by this Quarterly Report on Form 10-Q, our management, under the supervision and with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Exchange A…

• There were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the three months ended March 31, 2026.

Text removed vs the prior filing · source: 10-Q · 2025-11-13

• As of the end of the period covered by this Quarterly Report on Form 10-Q, our management, under the supervision and with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Exchange A…

• respects, our financial position, results of operations and cash flows for the periods presented in conformity with GAAP.

• Material Weaknesses in Internal Control Over Financial Reporting

• We previously identified a material weakness related to the design and maintenance of controls to prevent or detect material misstatements to our consolidated financial statements. Specifically, we did not design, implement and maintain an adequate review and approval process with respect to manual …

• We have implemented measures, and continue to be in the process of implementing additional measures, to improve our internal management review controls, including review and approval of journal entries. The material weakness will not be considered remediated until we complete the design and implemen…

Text added vs the prior filing · source: 10-Q · 2026-05-12

• The following table describes any contracts, instructions or written plans for the sale or purchase of our securities adopted, amended or terminated by our directors or executive officers during the three months ended March 31, 2026, each of which is intended to satisfy the affirmative defense condi…

• Name and TitleDate of Adoption of Rule 10b5-1 Trading PlanScheduled Expiration Date of Rule 10b5-1 Trading PlanAggregate Number of Securities to be Purchased or Sold

• During the three months ended March 31, 2026, no other director or Section 16 officer adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as such terms are defined under Item 408(a) of Regulation S-K.

Text removed vs the prior filing · source: 10-Q · 2025-11-13

• During the nine months ended September 30, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.